CAPOOR, M. N., F. S. AHMED, A. MCDOWELL a Ondřej SLABÝ. Is the "Common Cold" Our Greatest Ally in the Battle Against SARS-CoV-2? FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. LAUSANNE: FRONTIERS MEDIA SA, 2020, roč. 10, DEC 2020, s. 1-5. ISSN 2235-2988. Dostupné z: https://dx.doi.org/10.3389/fcimb.2020.605334.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Is the "Common Cold" Our Greatest Ally in the Battle Against SARS-CoV-2?
Autoři CAPOOR, M. N. (garant), F. S. AHMED, A. MCDOWELL a Ondřej SLABÝ (203 Česká republika, domácí).
Vydání FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, LAUSANNE, FRONTIERS MEDIA SA, 2020, 2235-2988.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30102 Immunology
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.293
Kód RIV RIV/00216224:14110/20:00118278
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.3389/fcimb.2020.605334
UT WoS 000603982400001
Klíčová slova anglicky SARS-CoV-2; COVID-19; T-cell; human coronaviruses; immunity; contact tracing; children
Štítky 14110513, podil, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 17. 3. 2021 14:09.
Anotace
The discovery of T-cell responses to SARS-CoV-2 in non-infected individuals indicates cross-reactive immune memory from prior exposure to human coronaviruses (HCoV) that cause the common cold. This raises the possibility that "immunity" could exist within populations at rates that may be higher than serology studies estimate. Besides specialized research labs, however, there is limited ability to measure HCoV CD4+ and CD8+ T-cell responses to SARS-CoV-2 infection, which currently impedes interpretation of any potential correlation between COVID-19 disease pathogenesis and the calibration of pandemic control measures. Given this limited testing ability, an alternative approach would be to exploit the large cohort of currently available data from which statistically significant associations may be generated. This would necessitate the merging of several public databases including patient and contact tracing, which could be created by relevant public health organizations. Including data from both symptomatic and asymptomatic patients in SARS-CoV-2 databases and surveillance systems could provide the necessary information to allow for more informed decisions.
VytisknoutZobrazeno: 20. 7. 2024 04:17